Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Varaine

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 6, 2012
Compassionate use of and expanded access to new drugs for drug-resistant tuberculosisC R Horsburgh, M Haxaire-Theeuwes, C Lienhardt, et al.
Public Health Action|April 10, 2019
Barriers and facilitators to early access of bedaquiline and delamanid for MDR-TB: a mixed-methods studyC A Rodriguez, M B Brooks, L Guglielmetti, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 6, 2013
Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regionsE Sanchez-Padilla, E Ardizzoni, D Sauvageot, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 29, 2015
The thin-layer agar method for direct phenotypic detection of multi- and extensively drug-resistant tuberculosisE Ardizzoni, W Mulders, T Kotrikadze, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 12, 2015
Routine use of Xpert® MTB/RIF in areas with different prevalences of HIV and drug-resistant tuberculosisA-L Page, E Ardizzoni, M Lassovsky, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 18, 2019
What will it take to eliminate drug-resistant tuberculosis?E A Kendall, S Sahu, M Pai, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 20, 2019
What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?M Bastard, E Sanchez-Padilla, A Hayrapetyan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 19, 2005
Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countriesM Bonnet, V Sizaire, Y Kebede, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 22, 2016
Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort studyM Bonnet, M Bastard, P du Cros, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1997
Meningitis outbreaks and vaccination strategyF Varaine, D A Caugant, J Y Riou, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 6, 2012
Compassionate use of and expanded access to new drugs for drug-resistant tuberculosisC R Horsburgh, M Haxaire-Theeuwes, C Lienhardt, et al.
Public Health Action|April 10, 2019
Barriers and facilitators to early access of bedaquiline and delamanid for MDR-TB: a mixed-methods studyC A Rodriguez, M B Brooks, L Guglielmetti, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 6, 2013
Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regionsE Sanchez-Padilla, E Ardizzoni, D Sauvageot, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 29, 2015
The thin-layer agar method for direct phenotypic detection of multi- and extensively drug-resistant tuberculosisE Ardizzoni, W Mulders, T Kotrikadze, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 12, 2015
Routine use of Xpert® MTB/RIF in areas with different prevalences of HIV and drug-resistant tuberculosisA-L Page, E Ardizzoni, M Lassovsky, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 18, 2019
What will it take to eliminate drug-resistant tuberculosis?E A Kendall, S Sahu, M Pai, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 20, 2019
What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?M Bastard, E Sanchez-Padilla, A Hayrapetyan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 19, 2005
Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countriesM Bonnet, V Sizaire, Y Kebede, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 22, 2016
Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort studyM Bonnet, M Bastard, P du Cros, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1997
Meningitis outbreaks and vaccination strategyF Varaine, D A Caugant, J Y Riou, et al.
Pageof 5